DefineMBC from Epic Sciences is the only blood-based biopsy that can provide ER & HER2 status in addition to genomic alterations. Discover more at definembc.com.
Epic Sciences’ Post
More Relevant Posts
-
This case highlights aortitis as a differential diagnosis for pyrexia of unknown origin, and the importance of distinguishing infective and non‐infective causes of aortitis to determine appropriate treatment https://ow.ly/h7nN50R6a5i
To view or add a comment, sign in
-
American #ginseng extract is extracted from the roots of the Panax quinquefolius. The main #active #ingredient is #ginsenoside, which has #anti-cancer, #antioxidant, cardiomyocyte #protection and neuro protective effects.
To view or add a comment, sign in
-
Helping mass tort attorneys acquire cases, not risk, through TCPA/FCC compliant ad campaigns with clear opt-in language. Our US-based intake team verifies the required injury and authenticates each claimant.
International Cancer Authority, IARC, upgraded the "forever chemical" PFOA to its highest "Group 1" category (carcinogenic to humans) yesterday, December 1, 2023 On March 14, 2023, the EPA said the “maximum contaminant level goal” (MCLG) for PFOA and PFOS is zero, meaning there is no safe contaminant level in drinking water. This might be a good time to launch your marketing campaign to educate and alert the public, including Firefighters, of the injuries. We're currently running campaigns for the listed injuries with a cost of acquisition of around $1900. However, demand and seasonal cost of media will impact COA. Don't delay; schedule a meeting to review the criteria. INJURIES: Cancers *Testicular *Kidney * Prostate *Bladder *Liver *Breast *Pancreatic *Ovarian *Non-Hodgkin's Lymphoma *Leukemia *Ulcerative Colitis *Hodgkin's Lymphoma *Thyroid Disease *Multiple Myeloma *Preeclampsia *High Cholesterol To discuss your marketing campaign, schedule a call: https://lnkd.in/gK2X-9qz 949-300-1478 samantha@goodplaintiffs.com Learn more: alltortsolutions.com #masstorts #PFAS #environmental #justice #toxic #firefighters #AFFF
IARC Monographs evaluate the carcinogenicity of PFOA and PFOS
https://www.youtube.com/
To view or add a comment, sign in
-
#CallforReading 🎉There are 12 papers that have been published in the #SpecialIssue "Multitasking #Proteins and Their Involvement in #Pathogenesis". #cellsmdpi #cellbiology ✨Enjoy reading link https://ow.ly/Tf3650PVt9J
To view or add a comment, sign in
-
Associate Professor of pediatric hematology oncology in Iran pediatric neuro-oncology consortium(IPINOC) scientific secretary Clinical informatics fellowship Medical education orientation
🛑Takeda TTP panel in ISTH 2024: Acquired thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder. ✅N-Acetylcysteine (NAC) rapidly degrades ultra-large von Willebrand factor multimers by disrupting the disulfide bonds. patients diagnosed with acquired TTP successfully treated with high-dose NAC (150 mg/kg/day) in combination with plasma exchange and steroids.
To view or add a comment, sign in
-
Field Application Specialist @Sartorius || Ex-Dr Reddy's Laboratories LTD || Ex-Biocon Bristol Myers Squibb R&D Centre || Ex-CCMB || IIT Delhi || NIBM || Alumni of Sri Ramachandra University|| Alumni of Jain University
Immune cells killing, or cytotoxicity, is a vital defense mechanism where immune cells eliminate infected or abnormal cells in the body. Incucyte from Sartorius, Our live cell imaging platform provides researchers with a powerful tool to visualize and study these dynamic interactions in real time. By leveraging this platform, researchers can gain insights into the mechanisms underlying immune cell killing. Kindly visit the link to explore further:
Incucyte®️ Cytolight Rapid, Annexin V and Caspase Dyes for Immune Cell Killing - find the solution to meet your application needs. Visit the eShop for more information. Order here: https://ow.ly/3jZg50QyAIf #LiveCellAnalysis #LiveCellImaging #ImmuneCells #Incucyte
To view or add a comment, sign in
-
At #ASH23, Dr. Justin M. Watts gave a presentation on a phase 1 study that explores the Bromodomain and Extra-Terminal Inhibitor INCB057643 (LIMBER-103) in #Patients with relapsed or refractory #Myelofibrosis and other advanced #Myeloid neoplasms.🔬Learn more: https://loom.ly/pV9CQVo
To view or add a comment, sign in
-
What to know on #SyngapAwarenessDay: This rare neurodevelopmental disorder is characterized by moderate to severe intellectual disability in early childhood. There are currently no approved treatments for Syngap1. We’re working with Acadia Pharmaceuticals Inc. to research a new way to treat the disease. Learn more: https://lnkd.in/eHTdbur5 #SYNGAP1
SYNGAP1 - Stoke Therapeutics
https://www.stoketherapeutics.com
To view or add a comment, sign in
-
Adalimumab monotherapy is the recommended first-line biologic treatment for children with Crohn disease. However, if infliximab is selected, combination therapy is preferable to monotherapy. https://brnw.ch/21wHele
To view or add a comment, sign in
-
📊 A study from Elaine Chang, MD, and colleagues investigated treatment-free #survival in patients with #aRCC. 👉 Learn more about their findings here:
Evaluating Treatment-Free Survival in Patients With Advanced RCC | GU Oncology Now
guoncologynow.com
To view or add a comment, sign in
13,319 followers